Akèy › Maladi Parkinson › Tennessee
Etid klinik pou Maladi Parkinson nan Tennessee
18 etid pou Maladi Parkinson ap chèche patisipan nan sit nan Tennessee.
Vil nan Tennessee
Tèks ofisyèl etid la (Anglè)
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- Vanderbilt University, Nashville
Ap rekriteFaz 2
Laj 40 a 80 · Tout sèks · Mizajou Oct 2, 2026 · NCT06680830A Study of Buntanetap in Participants With PD
- Neurology Clinic, P.C., Cordova
- Veracity Neuroscience LLC, Memphis
Ap rekriteFaz 2/3
Laj 40 a 85 · Tout sèks · Mizajou Sep 21, 2026 · NCT07284784Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- Vanderbilt University Medical Center, Nashville
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT01734122A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #016, Memphis
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 11, 2026 · NCT07804615A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- Vanderbilt University Medical Center (Site #204), Nashville
Ap rekriteFaz 2
Laj 30 a 80 · Tout sèks · Mizajou Sep 10, 2026 · NCT07432958Parkinson's Foundation PD GENEration Genetic Registry
- Vanderbilt University, Nashville
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT04994015A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Veracity Neuroscience, Memphis
- Vanderbilt University Medical Center, Nashville
Ap rekriteFaz 3
Laj 50 a 85 · Tout sèks · Mizajou Sep 3, 2026 · NCT07174310Physiological Brain Atlas Development
- Vanderbilt Univeristy, Nashville
Ap rekriteEtid obsèvasyon
Laj 6 a 90 · Tout sèks · Mizajou Aug 26, 2026 · NCT00575081Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
- Vanderbilt University Medical Center, Nashville
Ap rekriteFaz 4Volontè an sante akeyi
Laj 50 a 85 · Tout sèks · Mizajou Aug 7, 2026 · NCT05357612A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- Vanderbilt University Medical Center, Nashville
Ap rekriteFaz 3
Laj 45 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06944522Neurophysiology of Reward Signaling in Parkinson's Disease
- Vanderbilt University Medical Center, Nashville
Ap rekrite
Laj 40 ak plis · Tout sèks · Mizajou Jun 12, 2026 · NCT07409207Corticostriatal Contributions to Parkinson's Disease Cognitive Impairment
- Vanderbilt University Medical Center, Nashville
Ap rekrite
Laj 40 ak plis · Tout sèks · Mizajou Jun 12, 2026 · NCT04715984Natural History Study of Synucleinopathies
- Vanderbilt Univeristy, Nashville
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT01799915Use of CereGate Therapy for Freezing of Gait in PD
- Vanderbilt University Medical Center, Nashville
Ap rekrite
Laj 21 a 80 · Tout sèks · Mizajou May 28, 2026 · NCT05292794Effects of an Independent Walking Program With Walking Poles in People With Parkinson Disease
- East Tennessee State University, Johnson City
Ap rekrite
Tout laj · Tout sèks · Mizajou Apr 27, 2026 · NCT07551661CPAP for the Treatment of Supine Hypertension
- Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
Ap rekrite
Laj 40 a 80 · Tout sèks · Mizajou Apr 7, 2026 · NCT05489575[18F]F-DOPA Imaging in Patients With Autonomic Failure
- Vanderbilt University Medical Center, Nashville
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Mar 16, 2026 · NCT04246437Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
Ap rekriteFaz 1
Laj 40 a 80 · Tout sèks · Mizajou Oct 14, 2025 · NCT02897063Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.